View Older Stories View More Recent Stories
-
Form 13F-HR DEERFIELD MANAGEMENT CO For: Jun 30
-
SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update
-
Proteon Therapeutics Announces Second Quarter 2017 Financial Results
-
Proteon Therapeutics Announces Closing of $22 Million Convertible Preferred Stock Financing
-
Exelixis Announces Second Quarter 2017 Financial Results and Provides Corporate Update
-
Homology Medicines Announces $83.5 Million Series B Financing to Advance Lead Development Candidate and AMEnDR™ In Vivo Gene Editing Technology
-
Andrew ElBardissi, M.D. Named to NeoChord Board of Directors
-
AAC Holdings Simplifies Capital Structure and Expands Borrowing Capacity
-
MannKind (MNKD) Reports Exchange and Third Amendment to Facility Agreement with Deerfield
-
MannKind Renegotiates Near-Term Maturities with Deerfield
-
Exelixis Repays Deerfield Notes One Year Ahead of Maturity Date, Addressing Last Major Source of Indebtedness
-
Conventus Orthopaedics Strengthens Company Leadership
-
Proteon Therapeutics (PRTO) Announces $22M Private Placement of Series A Convertible Preferred Stock
-
Proteon Therapeutics Announces $22.0 Million Private Placement
-
AIT Therapeutics Announces Appointment of Steve Lisi as Chief Executive Officer
-
Nuo Therapeutics Restructures Series A Preferred Stock with Deerfield
-
Four plead not guilty to insider trading involving U.S. health agency
-
Five charged with insider trading involving U.S. health agency
-
Xeris Pharmaceuticals Announces Closing of $30 Million Financing
-
Form 13F-HR DEERFIELD MANAGEMENT CO For: Mar 31
-
SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update
-
Conventus Orthopaedics Raises $20 Million to Fund Revolutionary Cage™ Extremity Fracture Repair Therapy
-
Medical Properties Trust, Inc. Reports First Quarter Results
-
Solar Senior Capital Ltd. Announces Quarter Ended March 31, 2017 Financial Results; Declares Monthly Distribution of $0.1175 per Share for May, 2017
-
Solar Capital Ltd. Announces Quarter Ended March 31, 2017 Financial Results; Declares Quarterly Distribution of $0.40 per Share for Q2, 2017
-
Exelixis Announces First Quarter 2017 Financial Results and Provides Corporate Update
-
SteadyMed Ltd. (STDY) Announces $30M Private Placement of Ordinary Shares, Warrants
-
SteadyMed Raises $30 Million in Private Placement
-
Adeptus Health and Deerfield Join Forces to Enable High Quality Emergency Care
-
Adeptus Health (ADPT) Filed Voluntary Petitions for Relief Under Chapter 11
-
Adeptus Health and Deerfield Collaborate on Comprehensive Financial Restructuring Plan
-
Deerfield Management Company Invests $170 Million to Advance Aortic Disorder Treatment
-
Medical Properties Trust (MPW) PT Raised to $15 at Deutsche Bank
-
Endologix Enters into $170 Million Credit Facility with Deerfield Management
-
Medical Properties Trust, Inc. Describes Plans for Restructuring of Adeptus Health, Inc. Leases
-
Exelixis Further Reduces Indebtedness by Repaying Silicon Valley Bank Term Loan
-
SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results
-
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
-
Aralez Reports Fourth Quarter And Full-Year 2016 Financial Results
-
Solar Capital Ltd. and Solar Senior Capital Ltd. Announce the Formation of a First Lien Life Science Loan Program in Partnership With Deerfield Management
-
Solar Capital Ltd. and Solar Senior Capital Ltd. Announce the Formation of a First Lien Life Science Loan Program in Partnership With Deerfield Management
-
Rhythm Announces Completion of $41 Million Mezzanine Financing
-
Form 13F-HR DEERFIELD MANAGEMENT CO For: Dec 31
-
Deerfield Hires Vicki Gaddy as Head of Human Resource Strategy and Talent Acquisition
-
Chondrial Therapeutics Secures Up to $22.6 Million in Series A Financing and Licenses Novel Technology for the Treatment of Friedreich's Ataxia
-
Deerfield Hires Vicki Gaddy as Head of HR Strategy and Talent Acquisition
-
Deerfield Continues to Advance Healthcare Through the Publication of Novel Findings
-
PlacementTracker Publishes 2016 Private Placement Market League Tables
-
MD Anderson and Deerfield Management create Vescor LLC to develop novel therapeutics based on inhibiting autophagy for treatment of specific cancers
-
Oncorus®, Inc. Announces Additional Series A Financing Support From Astellas Venture Management LLC

